Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

CHIPPEWA COUNTY, Wis. (WEAU) - The Chippewa County Department of Public Health is announcing a new Public Health Kiosk ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Discover an unexpected link between common nosebleeds and serious health conditions. Learn the warning signs and when to seek medical attention.

Up to 11% of infants are born with a condition called tongue-tie where the small band of tissue under the tongue is too short, thick, or tight, limiting the tongue's mobility and preventing proper ...